Cantor Fitzgerald Sticks to Its Buy Rating for UnitedHealth (UNH)

Cantor Fitzgerald analyst Sarah James maintained a Buy rating on UnitedHealth (UNH – Research Report) yesterday and set a price target of $591.00. The company’s shares closed yesterday at $450.05.

James covers the Healthcare sector, focusing on stocks such as Cigna, UnitedHealth, and Humana. According to TipRanks, James has an average return of 13.3% and a 67.49% success rate on recommended stocks.

UnitedHealth has an analyst consensus of Strong Buy, with a price target consensus of $578.69, which is a 28.58% upside from current levels. In a report released yesterday, TD Cowen also maintained a Buy rating on the stock with a $546.00 price target.

UNH market cap is currently $420.4B and has a P/E ratio of 19.27.

Based on the recent corporate insider activity of 146 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of UNH in relation to earlier this year.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

UnitedHealth (UNH) Company Description:

UnitedHealth Group, Inc. is a diversified healthcare company, offering healthcare coverage and benefits services through UnitedHealthcare, and information and technology-enabled health services through Optum. The company was founded by Richard T. Burke in January 1977 and is headquartered in Minneapolis, MN.